Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression

Clinical Cancer Research

Volumn 3, Issue 8, 1997, Pages 1309-1316

  Itakura, Jun ^a   Ishiwata, Toshiyuki ^a   Friess, Helmut ^b   Fujii, Hideki ^c   Matsumoto, Yoshiro ^c   Büchler, Markus W ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ALTERNATIVE SPLICING; ANTIBODY SPECIFICITY; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RNA, MESSENGER; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030754056     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. American Cancer Society. Cancer Facts and Figures 1991. Atlanta: American Cancer Society, 1991.
2. Crist, D. W., Sitzmann, J. V., and Cameron, J. L. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann. Surg., 206: 358-365, 1987.
3. Trede, M. The surgical treatment of pancreatic carcinoma. Surgery, 97: 28-35, 1985.
4. Delcore, R., Thomas, J. H., and Hermreck, A. S. Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am. J. Surg., 162: 532-536, 1991.
5. Cameron, J. L., Pitt, H. A., Yeo, C. J., Lillemoe, K. D., Kaufman, H. S., and Coleman, J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann. Surg., 217: 430-438, 1993.
6. National Cancer Institute. Annual Cancer Statistics Review 1973-1988. NIH publication no. 91-2789. Bethesda, MD: Department of Health and Human Services, 1991.
7. Lillemoe, K. D., Sauter, P., Pitt, H. A., Yeo, C. J., and Cameron, J. L. Current status of surgical palliation of periampullary carcinoma. Surg. Gynecol. Obstet., 176: 1-10, 1993.
8. Folkmann, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
9. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5: 1806-1814, 1991.
10. Ferrara, N., Houck, K. A., Jakeman, L. B., and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev., 13: 18-32, 1992.
11. Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem., 271: 7788-7795, 1996.
12. Vries, C. D., Escobedo, J. A., Ueno, H., Houck, K. A., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
13. Terman, B. I., Vermazen, M. D., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Böhlen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1992.
14. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Möller, N. P. H., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
15. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
16. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045-1049, 1994.
17. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
18. Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54: 276-280, 1994.
19. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266: 11947-11954, 1991.
20. Hermaneck, P., and Sobin, L. H. UICC. TNM Classification of Malignant Tumors, pp. 65-68. New York: Springer-Verlag, 1987.
21. Friess, H., Yamanaka, Y., Büchler, M., Beger, H. G., Kobrin, M. S., Baldwin, R. L., and Korc, M. Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53: 2704-2707, 1993.
22. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Büchler, M. W., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Invest., 90: 1352-1360, 1992.
23. Balmain, A., Krumlauf, R., Vass, J. K., and Birnie, G. D. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids. Res., 10: 4259-4277, 1982.
24. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13, 1983.
25. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G. H., and Sato, J. D. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad. Sci. USA, 88: 5819-5823, 1991.
26. Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., Watanabe, Y., and Sasaki, T. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res., 2: 1411-1416, 1996.
27. Takahashi, Y., Cleary, K. R., Mai, M., Kitadai, Y., Bucana, C. D., and Ellis, L. M. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res., 2: 1679-1684, 1996.
28. Kaplan, E. L., and Meier, P. Non parametric estimation for incomplete information. Am. Statist. Assoc., 53: 457-481, 1958.
29. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., and Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35: 1-39, 1977.
30. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
31. Park, J. E., Keller, G. A., and Ferrara, N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell, 4: 1317-1326, 1993.
32. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest., 95: 1789-1797, 1995.
33. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes upregulate VEGF/ VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
34. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
35. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
36. Suzuki, K., Hayashi, N., Miyamoto, Y., Yamamoto, M., Ohkawa, K., Ito, Y., Sasaki, Y., Yamaguchi, Y., Nakase, H., Noda, K., Enomoto, N., Arai, K., Yamada, Y., Yoshihara, H., Tujimura, T., Kawano, K., Yoshikawa, K., and Kamada, T. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res., 56: 3004-3009, 1996.
37. Shifren, J. L., Doldi, N., Ferrara, N., Mesiano, S., and Jaffe, R. B. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrinol. Metab., 79: 316-322, 1994.
38. Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., Fujita, J., and Imamura, M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology, 23: 455-464, 1996.
39. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
40. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
41. Grünewald, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. G., and Bartram, C. R. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer, 43: 1037-1041, 1989.
42. Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X., and Perucho, M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J. Cancer, 58: 185-191, 1994.
43. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4: 121-133, 1993.
44. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
45. Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
46. Koochekpour, S., Merzak, A., and Pilkington, G. J. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoform in human glioma cells in vitro. Cancer Lett., 102: 209-215, 1996.
47. Ebert, M., Yokoyama, M., Kobrin, M. S., Friess, H., Lopez, M. E., Büchler, M. W., Johnson, G. R., and Korc, M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res., 54: 3959-3962, 1994.
48. Kobrin, M. S., Funatomi, H., Friess, H., Büchler, M. W., Stathis, P., and Korc, M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun., 202: 1705-1709, 1994.
49. Yamanaka, Y., Friess, H., Kobrin, M. S., Büchler, M. W., Beger, H. G., and Korc, M. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res., 13: 565-569, 1993.
50. Yokoyama, M., Funatomi, H., Kobrin, M. S., Ebert, M., Friess, H., Büchler, M. W., and Korc, M. Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int. J. Oncol., 7: 825-829, 1995.
51. Yamanaka, Y., Friess, H., Büchler, M., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., and Korc, M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res., 53: 5289-5296, 1993.
52. Friess, H., Yamanaka, Y., Büchler, M., Ebert, M., Beger, H. G., Gold, L. I., and Korc, M. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105: 1846-1856, 1993.
53. Ebert, M., Yokoyama, M., Friess, H., Kobrin, M. S., Büchler, M. W., and Korc, M. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer, 62: 529-535, 1995.
54. Ebert, M., Yokoyama, M., Friess, H., Büchler, M. W., and Korc, M. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res., 54: 5775-5778, 1994.